Search research articles
Contact Us
Filters
Showing results (31-40 of 129) with videos related to
Page
of 13
Sort By:
Journal of Hematology & Oncology
|
September 19, 2012
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
Bruno Vincenzi, Andrea Napolitano, Alice Zoccoli, et al.
Clinical Genitourinary Cancer
|
October 11, 2025
Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review
Anna Amela Valsecchi, Maria Concetta Cursano, Francesco Pantano, et al.
Cancers
|
September 1, 2019
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
Antonella Argentiero, Antonio Giovanni Solimando, Oronzo Brunetti, et al.
Anti-Cancer Drugs
|
January 14, 2020
Response to cabozantinib in renal cell carcinoma with cardiac metastases
Marco Stellato, Maria Concetta Cursano, Fabrizio Citarella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 16, 2014
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
Francesca Suriano, Daniele Santini, Giuseppe Perrone, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2024
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, et al.
Biology
|
August 27, 2021
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
Michele Iuliani, Sonia Simonetti, Francesco Pantano, et al.
Critical Reviews in Oncology/Hematology
|
September 18, 2017
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas
Bruno Vincenzi, Giuseppe Badalamenti, Andrea Napolitano, et al.
International Journal of Cancer
|
October 16, 2013
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials
Matteo Santoni, Alessandro Conti, Ugo De Giorgi, et al.
Expert Opinion on Therapeutic Targets
|
March 27, 2012
Premetastatic niche: ready for new therapeutic interventions?
Alice Zoccoli, Michele Iuliani, Francesco Pantano, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 129) with videos related to
Sort By:
Page
of 13
Journal of Hematology & Oncology
|
September 19, 2012
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
Bruno Vincenzi, Andrea Napolitano, Alice Zoccoli, et al.
Clinical Genitourinary Cancer
|
October 11, 2025
Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review
Anna Amela Valsecchi, Maria Concetta Cursano, Francesco Pantano, et al.
Cancers
|
September 1, 2019
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
Antonella Argentiero, Antonio Giovanni Solimando, Oronzo Brunetti, et al.
Anti-Cancer Drugs
|
January 14, 2020
Response to cabozantinib in renal cell carcinoma with cardiac metastases
Marco Stellato, Maria Concetta Cursano, Fabrizio Citarella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 16, 2014
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
Francesca Suriano, Daniele Santini, Giuseppe Perrone, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2024
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, et al.
Biology
|
August 27, 2021
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
Michele Iuliani, Sonia Simonetti, Francesco Pantano, et al.
Critical Reviews in Oncology/Hematology
|
September 18, 2017
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas
Bruno Vincenzi, Giuseppe Badalamenti, Andrea Napolitano, et al.
International Journal of Cancer
|
October 16, 2013
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials
Matteo Santoni, Alessandro Conti, Ugo De Giorgi, et al.
Expert Opinion on Therapeutic Targets
|
March 27, 2012
Premetastatic niche: ready for new therapeutic interventions?
Alice Zoccoli, Michele Iuliani, Francesco Pantano, et al.
Page
of 13